Maintenance Chemotherapy for Patients with Rhabdomyosarcoma

SIMPLE SUMMARY: The updated results of the RMS2005 randomized study confirm that patients with non-metastatic high risk rhabdomyosarcoma have an improved survival when maintenance chemotherapy (MC) with vinorelbine and low dose cyclophosphamide is added to the standard multidisciplinary treatment. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Bisogno, Gianni, Minard-Colin, Veronique, Jenney, Meriel., Ferrari, Andrea, Chisholm, Julia, Di Carlo, Daniela, Hjalgrim, Lisa Lyngsie, Orbach, Daniel, Merks, Johannes Hendrikus Maria, Casanova, Michela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417571/
https://www.ncbi.nlm.nih.gov/pubmed/37568826
http://dx.doi.org/10.3390/cancers15154012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417571/
https://www.ncbi.nlm.nih.gov/pubmed/37568826
http://dx.doi.org/10.3390/cancers15154012

Ejemplares similares